1. Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil‐to‐lymphocyte ratio in patients with metastatic renal cell carcinoma. Issue 11 (November 2016) Authors: Day, D.; Kanjanapan, Y.; Kwan, E.; Yip, D.; Lawrentschuk, N.; Davis, I. D.; Azad, A. A.; Wong, S.; Rosenthal, M.; Gibbs, P.; Tran, B. Journal: Internal medicine journal Issue: Volume 46:Issue 11(2016) Page Start: 1291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of emergent circulating tumor (ct) DNA RAS mutations in patients with metastatic colorectal cancer (mCRC) treated with panitumumab (pmab) monotherapy from the ASPECCT study. (December 2016) Authors: Kim, T.W.; Price, T.; Peeters, M.; Thomas, A.; Gibbs, P.; Hool, K.; Zhang, J.; Ang, A.; Bach, B. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Survival impact of the Australian National Bowel Cancer Screening Programme. Issue 2 (February 2016) Authors: Ananda, S.; Wong, H.; Faragher, I.; Jones, I. T.; Steele, M.; Kosmider, S.; Desai, J.; Tie, J.; Field, K.; Wong, R.; Tran, B.; Bae, S.; Gibbs, P. Journal: Internal medicine journal Issue: Volume 46:Issue 2(2016) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗